schizandrin b has been researched along with cryptotanshinone in 2 studies
Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (cryptotanshinone) | Trials (cryptotanshinone) | Recent Studies (post-2010) (cryptotanshinone) |
---|---|---|---|---|---|
321 | 1 | 218 | 370 | 0 | 268 |
9 | 0 | 7 | 370 | 0 | 268 |
Protein | Taxonomy | schizandrin b (IC50) | cryptotanshinone (IC50) |
---|---|---|---|
Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 90.06 | |
Lysine-specific histone demethylase 1A | Homo sapiens (human) | 9.02 | |
Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 0.8 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.722 | |
Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 10 | |
Signal transducer and activator of transcription 3 | Homo sapiens (human) | 4.6 | |
Tryptophan 2,3-dioxygenase | Homo sapiens (human) | 9.8 | |
Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 1.47 | |
Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 1.47 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chu, ZY; Tian, L; Wu, LH | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
2 other study(ies) available for schizandrin b and cryptotanshinone
Article | Year |
---|---|
[Determination of five components in rongxin pills by HPLC].
Topics: Abietanes; Chromatography, High Pressure Liquid; Cyclooctanes; Drugs, Chinese Herbal; Lignans; Linear Models; Organic Chemicals; Phenanthrenes; Polycyclic Compounds; Quality Control; Reproducibility of Results | 2014 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |